R. Entsuah

发表

Comprehensive Analysis of Remission (COMPARE) with Venlafaxine versus SSRIs

M. Thase, C. Nemeroff, M. Demitrack, 2008, Biological Psychiatry.

Leg ulcers in patients with sickle cell disease.

P. Levy, M. Koshy, A. Kraus, 1989, Blood.

Global benefit-risk comparison of venlafaxine/venlafaxine XR, selective serotonin reuptake inhibitors, and placebo

R. Entsuah, B. Gao, 2001, European Neuropsychopharmacology.

Disease Modification in Alzheimer’s Disease: Current Thinking

J. Schumi, H. Liu-Seifert, Xiaopeng Miao, 2019, Therapeutic innovation & regulatory science.

Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine

P. Silverstone, R. Entsuah, D. Hackett, 2002, International clinical psychopharmacology.

Venlafaxine versus placebo in the preventive treatment of recurrent major depression.

S. Montgomery, R. Entsuah, D. Hackett, 2004, The Journal of clinical psychiatry.

Measures for Conducting Comparative Benefit: Risk Assessment

Christy Chuang-Stein, Richard Entsuah, Yili Pritchett, 2008 .

Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo

S. K. Padmanabhan, P. Vinall, Charles Shelton, 2005, International clinical psychopharmacology.

Diabetic neuropathic pain management with venlafaxine extended release

V. Goli, R. Entsuah, R. Rudolph, 2000, European Neuropsychopharmacology.

A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder.

N. DeMartinis, P. Yeung, R. Entsuah, 2007, The Journal of clinical psychiatry.

Relapse prevention of panic disorder in adult outpatient responders to treatment with venlafaxine extended release.

Arif Khan, J. Ferguson, E. Tzanis, 2007, The Journal of clinical psychiatry.

A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder

N. Simon, M. Pollack, Ying Zhang, 2007, Psychopharmacology.

Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression

Richard Entsuah, Stephen M Stahl, S. Stahl, 2002, Biological Psychiatry.

A critical examination of the sensitivity of unidimensional subscales derived from the Hamilton Depression Rating Scale to antidepressant drug effects.

R. Entsuah, Jun Zhang, M. Shaffer, 2002, Journal of psychiatric research.

Potential Predictors of Placebo Response: Lessons from a Large Database

P. Vinall, R. Entsuah, 2007 .

A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder

N. Simon, M. Pollack, E. Tzanis, 2007, Psychopharmacology.

A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in adult outpatients with major depressive disorder.

M. Liebowitz, P. Yeung, R. Entsuah, 2007, The Journal of clinical psychiatry.

Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions.

M. Thase, M. Cantillon, S. Kornstein, 2005, Journal of women's health.

Early onset of antidepressant action of venlafaxine: pattern analysis in intent-to-treat patients.

A. Derivan, D. Kikta, R. Entsuah, 1998, Clinical therapeutics.

A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression.

L. Fabre, J. Feighner, K. Rickels, 1998, The Journal of clinical psychiatry.

Global Benefit-risk Evaluation of Antidepressant Action: Comparison of Pooled Data for Venlafaxine, SSRIs, and Placebo

R. Entsuah, B. Gao, 2002, CNS Spectrums.

Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features

M. Thase, C. Nemeroff, D. Sheehan, 2009, International clinical psychopharmacology.

Etrank: a ranking procedure for handling missing data in clinical trials: application to venlafaxine extended-release depression clinical trial.

R. Entsuah, 1996, Journal of biopharmaceutical statistics.

A meta-analysis of the effects of venlafaxine on anxiety associated with depression.

R. Entsuah, R. Rudolph, R. Chitra, 1998, Journal of clinical psychopharmacology.

Global benefit-risk assessment of antidepressants: venlafaxine XR and fluoxetine.

Richard Entsuah, J. Gorman, Jack M Gorman, 2002, Journal of psychiatric research.

Efficacy of venlafaxine treatment in depressed patients with psychomotor retardation or agitation: A metaanalysis

G. V. Upton, R. Entsuah, R. Rudolph, 1995 .

The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group.

ArifUllah Khan, R. Entsuah, Upton Gv, 1998, Journal of clinical psychopharmacology.

Rapid onset of antidepressant activity with venlafaxine treatment

K. Rickels, A. Derivan, R. Entsuah, 1995 .

Venlafaxine prevents recurrence of depression

R. Entsuah, D. Hackett, R. Rudolph, 1998, European Neuropsychopharmacology.

Early onset of antidepressant activity of venlafaxine compared with placebo and fluoxetine in outpatients in a double-blind study

A. Derivan, R. Entsuah, R. Rudolph, 1998, European Neuropsychopharmacology.

Handling Intercurrent Events Through Hypothetical Strategy in Delayed-Start Designs

G. Liu, R. Entsuah, Fang Liu, 2021, Statistics in Biopharmaceutical Research.

Disease Modification in Alzheimer’s Disease: Current Thinking

J. Schumi, H. Liu-Seifert, Xiaopeng Miao, 2020, Therapeutic Innovation & Regulatory Science.

A comparative analysis between venlafaxine and selective serotonin reuptake inhibitors (SSRIs) on remission for patients with major depressive disorder

E. Salinas, R. Entsuah, R. Rudolph, 1999, European Neuropsychopharmacology.

Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.

A. Schatzberg, Jieling Chen, R. Mallick, 2003, The Journal of clinical psychiatry.

Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features

M. Thase, C. Nemeroff, D. Sheehan, 2009, International clinical psychopharmacology.